Mark Crowther: Evidence-Based Guidance for Anticoagulant Prophylaxis in Children
Mark Crowther, University Professor and Chair, Department of Medicine at McMaster University, Fellow at Canadian Academy of Health Sciences, shared American Society of Hematology’s post on LinkedIn:
“Congratulations to the authors on this important work – Pediatric thrombosis has been generally overlooked despite it being a cause of significant morbidity that can last for years.
Great work by the American Society of Hematology on building its stable of Guideline initiatives.”
American Society of Hematology shared a post on LinkedIn:
“ASH and ISTH have released new clinical practice guidelines on anticoagulant prophylaxis for pediatric patients at risk of VTE, offering long-awaited, evidence-based recommendations to support care for some of the most vulnerable children.
With VTE on the rise in pediatric populations, these guidelines provide critical clarity for clinicians and highlight areas where more research is needed.
Explore the recommendations and resources in the press release.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics